Short answer
Aveanna Healthcare Holdings, Inc. (AVAH) filed its Q3 2025 10-Q quarterly report on Nov 6, 2025 for the quarter ended Sep 27, 2025. Quarterly revenue was $622M (up 22.2% year over year) with net income of $14M.
Q3 2025 key financials · XBRL
- Revenue
- $622M
- +22.2% YoY · +5.5% QoQ
- Net income
- $14M
- +132.8% YoY · −48.0% QoQ
- Operating margin
- 8.6%
- Gross margin
- 32.6%
- EPS (diluted)
- $0.06
- +127.3% YoY · −53.8% QoQ
Source: XBRL data from the Aveanna Healthcare Holdings, Inc. (AVAH) Q3 2025 10-Q on SEC EDGAR. USD.
Aveanna Healthcare Holdings, Inc. Q3 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $621.9M, up 22.2% YoY from $509.0M
- Gross margin 32.6% vs 31.4%; operating margin 8.6% vs 6.7%
- Best segment PDS revenue $514.4M, up 25.6%; gross margin 29.0% vs 26.8%
- Worst segment MS revenue $45.1M, down 0.5%; gross margin 45.0% vs 45.6%
- Near-term headwinds: proposed CY 2026 CMS rule could reduce HHH reimbursement 6.4%; OBBBA projects $1.15T Medicaid spending reduction over ten years
Risk Factors
- No risk-factor section provided; excerpt begins with Item 2 and contains no comparison to the most recent 10-K
- Credit agreement amended September 17, 2025 through a Fourth Joinder and Twelfth Amendment to the First Lien Credit Agreement
- Securities-trading compliance risk: Chief Compliance Officer adopted sell-to-cover plans permitting up to 75,000 and 136,204 shares sold
- Equity dilution risk: trading arrangements expire January 9, 2026 and February 28, 2026, respectively
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Aveanna Healthcare Holdings, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.